World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
75
Citations
17450
World Ranking
2044
National Ranking
972

Richard Hargreaves publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Richard Hargreaves sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 260 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Richard Hargreaves D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Hargreaves sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 75 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Richard Hargreaves is affiliated with Harvard Medical School in the United States. Their research focuses primarily on medicine, with particular attention to subfields including cognitive neuroscience, physiology, and pharmacology.

The main topics addressed in their work encompass pain management and the placebo effect, pain mechanisms and treatments, as well as musculoskeletal pain and rehabilitation.

Recent publications by Richard Hargreaves include the following papers:

  • Enhancing Choice and Outcomes for Therapeutic Trials in Chronic Pain: N-of-1 + Imaging (+ i), 2020, published in Trends in Pharmacological Sciences
  • Saving the Quality, 2020, published in Yale University Press eBooks

Frequent coauthors collaborating with Richard Hargreaves are:

  • David Borsook
  • Jaymin Upadhyay
  • Tor D. Wager

Publication venues where their work has appeared include:

  • Trends in Pharmacological Sciences
  • Yale University Press eBooks

Best Publications

  • Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors

    Mark S. Kramer;Neal Cutler;John Feighner;Ram Shrivastava

  • Thalamic sensitization transforms localized pain into widespread allodynia.

    Rami Burstein;Rami Burstein;Moshe Jakubowski;Esther Garcia-Nicas;B A Vanessa Kainz

  • [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor

    H. Donald Burns;Koen Van Laere;Sandra Sanabria-Bohórquez;Terence G. Hamill

  • Lack of Efficacy of the Substance P (Neurokinin1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder

    Martin Keller;Stuart Montgomery;William Ball;Mary Morrison

  • Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists

    P.J. Hesketh;S. Van Belle;M. Aapro;F.D. Tattersall

  • Neurogenic inflammation in the context of migraine.

    David J. Williamson;Richard J. Hargreaves

  • Intravital Microscope Studies on the Effects of Neurokinin Agonists and Calcitonin Gene-Related Peptide on Dural Vessel Diameter in the Anaesthetized Rat:

    DJ Williamson;RJ Hargreaves;RG Hill;SL Shepheard

  • A role for fMRI in optimizing CNS drug development

    David Borsook;Lino Becerra;Richard Hargreaves

  • Painful Heat Reveals Hyperexcitability of the Temporal Pole in Interictal and Ictal Migraine States

    E. A. Moulton;L. Becerra;N. Maleki;G. Pendse

  • Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist

    J. J. Hale;S. G. Mills;M. Maccoss;P. E. Finke

  • Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies.

    DJ Williamson;RJ Hargreaves;RG Hill;SL Shepheard

  • The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake.

    Carol Addy;Hamish Wright;Koen Van Laere;Ira Gantz

  • Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets.

    F.D. Tattersall;W. Rycroft;B. Francis;D. Pearce

  • Interictal dysfunction of a brainstem descending modulatory center in migraine patients.

    Eric A. Moulton;Rami Burstein;Shannon Tully;Richard Hargreaves

  • Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats

    S. L. Shepheard;D. J. Williamson;John Williams;R. G. Hill

  • Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant.

    Mats Bergström;Richard J Hargreaves;H.Donald Burns;Michael R Goldberg

  • Imaging substance P receptors (NK1) in the living human brain using positron emission tomography.

    Richard Hargreaves

  • The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.

    David J. Williamson;Sara L. Shepheard;Raymond G. Hill;Richard J. Hargreaves

  • Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults.

    Ngozi Erondu;Ira Gantz;Bret Musser;Shailaja Suryawanshi

  • Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers

    Terence G. Hamill;Stephen Krause;Christine Ryan;Celine Bonnefous

  • Rizatriptan has central antinociceptive effects against durally evoked responses.

    Michael J Cumberbatch;Raymond G Hill;Richard J Hargreaves

Frequent Co-Authors

David Borsook
David Borsook Boston Children's Hospital
Lino Becerra
Lino Becerra Harvard Medical School
John R. Atack
John R. Atack Cardiff University
Margaret A. Cascieri
Margaret A. Cascieri MSD (United States)
Smriti Iyengar
Smriti Iyengar Eli Lilly (United States)
John J. Renger
John J. Renger MSD (United States)
Raymond Baker
Raymond Baker MSD (United States)
Sander G. Mills
Sander G. Mills MSD (United States)
Jarmo Hietala
Jarmo Hietala Turku University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in neuroscience, exploring alternative online education options can help you advance your studies while accommodating your schedule or budget. Many universities now offer accelerated bachelor's degree online programs, allowing you to complete your degree in a shorter timeframe and enter the workforce or graduate school sooner.

Choosing a major is a crucial step, especially if you’re motivated by future financial stability. If you’re asking, "what bachelors degree should i get," it’s important to consider your career goals, interests, and potential earnings. Neuroscience is academically rigorous, but there are also degrees in health sciences, engineering, and technology that frequently rank as higher-paying fields.

Those who want to maximize their earning potential should review the latest findings on what degrees make the most money. This information can help you align your educational pathway with rewarding career outcomes, whether within neuroscience or a related discipline.

Cost is another critical consideration. Students seeking an affordable education can explore options through cheap online colleges that accept fafsa. This enables you to receive financial aid, complete your studies online, and minimize student debt.

Best Scientists Citing Richard Hargreaves

Trending Scientists

Recently Published Articles